Issues related to Medicare coverage for certain cancer therapies
Issues related to Comparative Effectiveness Medicare/Medicaid and other general health issues. S. 1145, Patent Reform Act of 2007, entire bill
H.R. 1908, Patent Reform Act of 2007, entire bill House Concurrent Resolution 312 FY09 Budget Resolution
Senate Concurrent Resolution 70 FY09 Budget Resolution
Drug Importation
Comparative Effectiveness LHHS Appropriations
Homeland Appropriations
Agriculture Appropriations H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics
H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
H. R. 5629, Pathway for Biosimilars Act
S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
S. 2029, Physician Payments Sunshine Act of 2007
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 5480, Medicare Funding Warning Response Act of 2008
S. 2029, Physician Payments Sunshine Act of 2007
S. 2662, Medicare Funding Warning Response Act of 2008
S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill
Comparative Effectiveness
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
S. 3101, Medicare Improvements for Patients and Providers Act of 2008
H.4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions
HCR - Health Issues MED - Medical/Disease Research/Clinical Labs CPT - Copyright/Patent/Trademark BUD - Budget/Appropriations PHA - Pharmacy MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
750 9th Street N.W. Suite 575, WASHINGTON, DC, 20001, US
MICHAEL J EGING THOMAS JOHN FUSSARO MICHAEL J EGING THOMAS JOHN FUSSARO MICHAEL J EGING THOMAS JOHN FUSSARO MICHAEL J EGING THOMAS JOHN FUSSARO MICHAEL J EGING THOMAS JOHN FUSSARO MICHAEL J EGING THOMAS JOHN FUSSARO